Carbamazepine toxicity: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "*Tintinalli" to "") |
Neil.m.young (talk | contribs) (Text replacement - " pt " to " patient ") |
||
| Line 25: | Line 25: | ||
==Disposition== | ==Disposition== | ||
*Consider discharge for | *Consider discharge for patient with decreasing levels (measured few hrs apart) and is asymptomatic | ||
==References== | ==References== | ||
Revision as of 18:48, 1 July 2016
Background
- Has anticholinergic and antiepileptic effects
- Therapeutic concentration: 4-12
Clinical Features
- May be delayed and follow crescendo-decrescendo course (due to delayed GI motility)
- CNS
- Ataxia
- Nystagmus
- Coma
- Anticholinergic Toxicity
- CV
- Dysrhythmias are rare but may occur
- Wide QRS
- QT Prolongation
Diagnosis
- Levels do not accurately correlate w/ clinical severity
Treatment
- GI detox
- Activated Charcoal (if presents w/in 1hr of ingestion)
- Dialysis is effective (if needed)
Disposition
- Consider discharge for patient with decreasing levels (measured few hrs apart) and is asymptomatic